Two generic drug companies — Teva Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. — agreed Wednesday to pay a combined $2.15 billion to settle patent litigation with Pfizer Inc. over the drug Protonix.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to firstname.lastname@example.org to learn more.